Can-Fite Biopharma LTD. 6-K Filing
Ticker: CANF · Form: 6-K · Filed: Nov 21, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Nov 21, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $0.60, $0.467 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Can-Fite Biopharma LTD. (ticker: CANF) to the SEC on Nov 21, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.60 (he exercise price of such warrants from $0.60 per ADS to $0.467 per ADS. 1 SIGNATUR); $0.467 (of such warrants from $0.60 per ADS to $0.467 per ADS. 1 SIGNATURES Pursuant to t).
How long is this filing?
Can-Fite Biopharma LTD.'s 6-K filing is 1 pages with approximately 276 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 276 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2025-11-21 16:30:27
Key Financial Figures
- $0.60 — he exercise price of such warrants from $0.60 per ADS to $0.467 per ADS. 1 SIGNATUR
- $0.467 — of such warrants from $0.60 per ADS to $0.467 per ADS. 1 SIGNATURES Pursuant to t
Filing Documents
- ea0266572-6k_canfite.htm (6-K) — 9KB
- 0001213900-25-113637.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 21, 2025 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 2